Norway· NO-ID_73FE8105-2142-47DC-BDB4-0DF5CFA0953E
Mydriasert
A tropicamid, kombinationen product containing phenylephrine hydrochloride + tropicamide, registered in Norway by Laboratoires Théa. The same ATC class is registered in 10 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Tropicamid, kombinationen is registered in 10 of 19 countries.
Countries holding a registration under ATC S01FA56 (tropicamid, kombinationen), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Tropicamid, kombinationen · ATC S01FA56
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FEST (Norway)- Active substance
- Phenylephrine Hydrochloride + Tropicamide
- Manufacturer
- Laboratoires Théa
- Country
- Norway (NO)
- ATC code
- S01FA56
- ATC class
- Tropicamid, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 2
- no_varenummer35625620
- no_merkevare_idID_73FE8105-2142-47DC-BDB4-0DF5CFA0953E
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tropicamid, kombinationen in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsMydriasert, ooginsert 0,28 mg en 5,4 mgEuro Registratie Collectief B.V.
- SwitzerlandMydriasert, insert ophtalmiqueTHEA Pharma S.A.
- SpainMYDRIASERT 0,28 mg/5,4 mg INSERTO OFTALMICOLaboratoires Thea
- FinlandMydriasertLaboratoires Thea
- FranceMYDRIASERT, insert ophtalmiqueTHEA
- United KingdomMydriasert 5.4mg/0.28mg ophthalmic insertsThea Pharmaceuticals Ltd
- SwedenMydriasert 0,28 mg/5,4 mg ÖgonlamellLaboratoires THEA
- GermanyMydriasertLaboratoires Thea
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Mydriasert
- Belgium · Mydriasert
- Germany · Mydriasert
- Denmark · Mydriasert
- Spain · Mydriasert
- Finland · Mydriasert
- France · Mydriasert
- United Kingdom (Northern Ireland) · Mydriasert
- Italy · Mydriasert, Visumidriatic Fenilefrina
- Luxembourg · Mydriasert
- Netherlands · Mydriasert
- Portugal · Mydriasert
- Sweden · Mydriasert
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/405f56f3-dfef-4ff5-a457-267324017a1d GET /v1/drugs/405f56f3-dfef-4ff5-a457-267324017a1d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Øyelamell",
"source": "fest",
"status": "A",
"atc_name": "Tropikamid, kombinasjoner",
"merkevare_id": "ID_73FE8105-2142-47DC-BDB4-0DF5CFA0953E",
"name_form_strength": "Mydriasert øyelamell 0,28 mg/5,4 mg",
"prescription_group": "C"
}See everything about tropicamid, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.